Abstract
Obesity is a chronic non-communicable disease whose prevalence has doubled during the last three decades, becoming, along with its metabolic complications, a worldwide public health problem. Recently, the alteration of the intestinal microbiota balance, known as dysbiosis, has been identified as a possible pathophysiological process that promotes weight gain in individuals who suffer from it. Dietary intervention with prebiotics, probiotics, or symbiotics aimed at correcting intestinal dysbiosis in obese patients can provide health benefits by facilitating weight loss and maintenance, improving constipation, glucose, and lipid levels, as well as immunity and expression of regulatory cytokines, thus contributing to the reduction of the chronic inflammatory process of intestinal cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
